Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...

If you’re new to generators, you’ve probably found yourself asking: What’s an inverter generator? It’s a term that pops up as soon as you start doing research. Inverter generators are more expensive ...

Among the various frameworks of this server-side scripting language, two of the most powerful are CodeIgniter and Laravel. Both are different and showcase different features and capabilities. Laravel ...

It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier. Absci CEO Sean McClain — tall, with short, gelled hair and a beard, the ...

The Codeigniter 4 Route Generator is a PHP package designed to automate the generation of routes for CodeIgniter 4 applications. It scans your controller classes, extracts route information from ...

Make your chats more interesting with Image Playground in the Messages app, which can create an AI version of existing photos or generate new ones from your prompts. I've written for various ...

Flagship Pioneering-backed artificial intelligence start-up Generate:Biomedicines has attracted another big pharma partnership, this time with Novartis. The wide-ranging deal, worth up to $1 billion, ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines (“Generate”) today announced a multi-target collaboration with Novartis (NYSE: NVS) to discover and develop protein therapeutics across ...